Testing effectiveness (Phase 2)Looking for participantsNCT04333706
What this trial is testing
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
Who this might be right for
BreastMetastaticTriple Negative+2 more
University of Southern California 65